tirzepatide and cannabis ADA 2025: Advances in Type 2 Diabetes Management With GLP-1 boom nudges cannabis dispensaries

Metabolic Optimization Even at sub-therapeutic doses, GLP-1 receptor agonists improve insulin sensitivity, reduce post-meal glucose excursions, decrease appetite, and support favorable shifts in body composition

When blood sugar stays steadier, you aren't riding the familiar spike and crash cycle that usually triggers sugar cravings

Add RMR testing to optimize your metabolic health and nutrition approach

However, one missed dose doesnt mean youve derailed your progress

adults were using GLP-1 medications as of November, either for weight loss or to manage chronic conditions like diabetes, according to a Kaiser Family Foundation study